"ALL-MED" Specjalistyczna Opieka Medyczna Medyczny Instytut Badawczy
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jutel, Marek
SWIFT-1, NCT04719832 / 2020-003632-25: Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Recruiting
3
375
Europe, Canada, US, RoW
GSK3511294 (Depemokimab), Placebo
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
09/23
09/23

Download Options